Home Commercial trading MSP RECOVERY INVESTOR ALERT: Kaplan Fox investigates

MSP RECOVERY INVESTOR ALERT: Kaplan Fox investigates


NEW YORK, June 02, 2022 (GLOBE NEWSWIRE) — Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of MSP Recovery Inc. (“MSP Recovery” or the “Company”) (NASDAQ: MSPR; MSPRZ), a Medicare, Medicaid, commercial and secondary reimbursement recovery company that claims to use data – solutions focused on securing recoveries against health care reimbursement officials.

On May 24, 2022, following the completion of a business combination with Lionheart Acquisition Corporation II (“LCAP”), MSP Recovery shares began trading on NASDAQ. In May 24 trading, MSP Recovery stock fell more than 50% to close at $5.06 per share.

On May 25, 2022, Forbes published an article stating, among other things, that “the ‘central tension’ of MSP Recovery is that it has not argued its claims and therefore it is difficult to assess its monetary value”. Following the release, shares continued to decline, closing at $3.73 per share.

Then, on May 26, 2022, the Company issued a press release challenging Forbes article and reaffirming its revenue forecast. MSP Recovery shares, however, continued to drop in price significantly the rest of the week to close at $1.74 per share on May 27, 2022.

If you have purchased or otherwise acquired shares in MSP Recovery securities and would like to discuss our investigation, please contact us by email [email protected] or by calling (646) 315-9003.

This press release may be considered attorney advertising in certain jurisdictions under applicable law and ethics rules.

Kaplan Fox & Kilsheimer LLP, with offices in New York, San Francisco, Los Angeles, Chicago and New Jersey, has many years of experience pursuing investor class actions. For more information about Kaplan Fox & Kilsheimer LLP, you can visit our website at www.kaplanfox.com. If you have any questions about this survey, your rights or your interests, please contact:

Donald R Hall
850 Third Avenue, 14th Floor
New York, New York 10022
(646) 315-9003
E-mail: [email protected]

Laurence D. King
1999 Harrison Street, Suite 1560
Oakland, California 94612
(415) 772-4704
Fax: (415) 772-4707
E-mail: [email protected]